6OVA Stock Chart & Stats
€4.04
€0.18(4.46%)
At close: 4:00 PM EDT
€4.04
€0.18(4.46%)
Day’s Range― - ―
52-Week Range€4.00 - €8.90
Previous CloseN/A
Volume0.00
Average Volume (3M)44.00
Market Cap
€274.32M
Enterprise Value€333.76
Total Cash (Recent Filing)€121.27M
Total Debt (Recent Filing)€2.60M
Price to Earnings (P/E)57.8
Beta0.47
Next Earnings
Aug 06, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.12
Shares Outstanding63,412,163
10 Day Avg. Volume17
30 Day Avg. Volume44
Financial Highlights & Ratios
PEG Ratio1.48
Price to Book (P/B)2.08
Price to Sales (P/S)5.09
P/FCF Ratio70.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€7.93Price Target Upside96.36% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)0.17
Revenue Forecast (FY)€82.11M
Bulls Say, Bears Say
Bulls Say
Very Low LeverageVitalhub’s minimal leverage (debt-to-equity ~0.01) provides durable financial flexibility. Low interest and refinancing risk allow the company to allocate capital to product development, support and selective M&A, supporting long-term solvency and strategic optionality.
High Gross & EBITDA MarginsSustained high gross margin (~74.8%) and robust EBITDA margin (~20.3%) reflect strong software economics and operating leverage. These durable margins support reinvestment in R&D and sales while providing a buffer versus pricing or cost pressures, aiding long-term profitability.
Recurring Software Revenue ModelA recurring revenue mix (licenses, subscriptions, maintenance/support) creates predictable, contract-backed cash flows and higher customer switching costs. Coupled with historically solid free cash flow, this underpins durable revenue visibility, retention and reinvestment capacity.
Bears Say
Weak Cash ConversionOperating cash flow to net income (~0.11 TTM) signals poor near-term cash conversion, likely from working-capital timing or integration costs. If persistent, this reduces internal funding for growth, increases reliance on external capital, and weakens earnings quality over time.
Margin Pressure & Moderate Net MarginA declining gross-margin trend and only moderate net margin (~6.1%) suggest less favorable mix or rising costs. Continued margin erosion would limit free cash flow growth and constrain the ability to fund innovation or pay down capital, pressuring long-term profitability.
Modest ROE Vs Equity GrowthROE around ~3.0% while equity has scaled indicates returns aren't keeping pace with capital growth. This can reflect dilution from acquisitions or integration costs; unless ROIC improves, shareholder returns may remain muted over the medium term.
Vitalhub News
6OVA FAQ
What was Vitalhub’s price range in the past 12 months?
Vitalhub lowest stock price was €4.00 and its highest was €8.90 in the past 12 months.
What is Vitalhub’s market cap?
Vitalhub’s market cap is €274.32M.
When is Vitalhub’s upcoming earnings report date?
Vitalhub’s upcoming earnings report date is Aug 06, 2026 which is in 5 days.
How were Vitalhub’s earnings last quarter?
Vitalhub released its earnings results on May 07, 2026. The company reported €0.025 earnings per share for the quarter, missing the consensus estimate of €0.037 by -€0.012.
Is Vitalhub overvalued?
According to Wall Street analysts Vitalhub’s price is currently Undervalued.
Does Vitalhub pay dividends?
Vitalhub does not currently pay dividends.
What is Vitalhub’s EPS estimate?
Vitalhub’s EPS estimate is 0.04.
How many shares outstanding does Vitalhub have?
Vitalhub has 63,412,163 shares outstanding.
What happened to Vitalhub’s price movement after its last earnings report?
Vitalhub reported an EPS of €0.025 in its last earnings report, missing expectations of €0.037. Following the earnings report the stock price went up 2.893%.
Which hedge fund is a major shareholder of Vitalhub?
Currently, no hedge funds are holding shares in DE:6OVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vitalhub Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€7.93 (96.36% Upside)
€7.93 (96.36% Upside)
Blogger Sentiment
Bullish
DE:6OVA Sentiment 100%
Sector Average ―
Sector Average ―
Technicals
SMA
Negative
20 days / 200 days
Momentum
9.71%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
51.17%
Trailing 12-Months
Company Description
Vitalhub
Vitalhub Corp., through its subsidiaries, provides innovative technological solutions to health and human service providers internationally, specifically catering to markets in Canada, the United States, the United Kingdom, Australia, and Western Asia. The company's diverse array of offerings comprises electronic healthcare records, case management systems, care coordination platforms, tools for optimizing patient flow and operational insights, and various mobile applications. Incorporated in 2010, Vitalhub is headquartered in Toronto, Canada.
6OVA Stock 12 Month Forecast
Average Price Target
€7.93
▲(96.36% Upside)
Technical Analysis
Diagnos
―
kneat.com
―
nDatalyze Corp
―
Comprehensive Healthcare Systems Inc
―
UniDoc Health Corp
―